EVOLUTIONARY REVERSALS OF ANTIBIOTIC RESISTANCE IN EXPERIMENTAL POPULATIONS OF PSEUDOMONAS AERUGINOSA

被引:24
|
作者
Gifford, Danna R. [1 ]
MacLean, R. Craig [1 ]
机构
[1] Univ Oxford, Dept Zool, Oxford OX1 2JD, England
基金
加拿大自然科学与工程研究理事会;
关键词
Compensatory evolution; evolvability; genetic drift; probability of fixation; rifampicin; BENEFICIAL MUTATIONS; ESCHERICHIA-COLI; BIOLOGICAL COST; COMPENSATORY EVOLUTION; EVOLVABILITY; SELECTION; PERSISTENCE; ADAPTATION; MECHANISMS; BACTERIA;
D O I
10.1111/evo.12158
中图分类号
Q14 [生态学(生物生态学)];
学科分类号
071012 ; 0713 ;
摘要
Antibiotic resistance mutations are accompanied by a fitness cost, and two mechanisms allow bacteria to adapt to this cost once antibiotic use is halted. First, it is possible for resistance to revert; second, it is possible for bacteria to adapt to the cost of resistance by compensatory mutations. Unfortunately, reversion to antibiotic sensitivity is rare, but the underlying factors that prevent reversion remain obscure. Here, we directly study the evolutionary dynamics of reversion by experimentally mimicking reversion mutationssensitivesin populations of rifampicin-resistant Pseudomonas aeruginosa. We show that, in our populations, most sensitives are lost due to genetic drift when they are rare. However, clonal interference from lineages carrying compensatory mutations causes a dramatic increase in the time to fixation of sensitives that escape genetic drift, and mutations surpassing the sensitives' fitness are capable of driving transiently common sensitive lineages to extinction. Crucially, we show that the constraints on reversion arising from clonal interference are determined by the potential for compensatory adaptation of the resistant population. Although the cost of resistance provides the incentive for reversion, our study demonstrates that both the cost of resistance and the intrinsic evolvability of resistant populations interact to determine the rate and likelihood of reversion.
引用
收藏
页码:2973 / 2981
页数:9
相关论文
共 50 条
  • [41] Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis
    Gillham, M. I.
    Sundaram, S.
    Laughton, C. R.
    Haworth, C. S.
    Bilton, D.
    Foweraker, J. E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (04) : 728 - 732
  • [42] Antibiotic resistance in Pseudomonas aeruginosa and adaptation to complex dynamic environments
    Sommer, Lea M.
    Johansen, Helle K.
    Molin, Soren
    MICROBIAL GENOMICS, 2020, 6 (05):
  • [43] Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective
    Subedi, Dinesh
    Vijay, Ajay Kumar
    Willcox, Mark
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2018, 101 (02) : 162 - 171
  • [44] Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
    Pang, Zheng
    Raudonis, Renee
    Glick, Bernard R.
    Lin, Tong-Jun
    Cheng, Zhenyu
    BIOTECHNOLOGY ADVANCES, 2019, 37 (01) : 177 - 192
  • [45] Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units
    Vojtova, Vladimira
    Hajdu, Dominika
    Kolar, Milan
    Urbanek, Karel
    PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 308 - 308
  • [46] Evolution of Antibiotic Resistance in Patients with Pseudomonas Aeruginosa Pneumonia in the ICU
    Treadway, J.
    Wunderink, R. G.
    Qi, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [47] Characteristics of Antibiotic Resistance and Tolerance of Environmentally Endemic Pseudomonas aeruginosa
    Kim, Seryoung
    Masai, Satomi
    Murakami, Keiji
    Azuma, Momoyo
    Kataoka, Keiko
    Sebe, Mayu
    Shimizu, Kazuya
    Itayama, Tomoaki
    Whangchai, Niwooti
    Whangchai, Kanda
    Ihara, Ikko
    Maseda, Hideaki
    ANTIBIOTICS-BASEL, 2022, 11 (08):
  • [48] Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance
    Dambrauskiene, Asta
    Adukauskiene, Dalia
    Jeroch, Jolanta
    Vitkauskiene, Astra
    MEDICINA-LITHUANIA, 2009, 45 (01): : 1 - 7
  • [49] Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres
    Smith, Daniel J.
    Ramsay, Kay A.
    Yerkovich, Stephanie T.
    Reid, David W.
    Wainwright, Claire E.
    Grimwood, Keith
    Bell, Scott C.
    Kidd, Timothy J.
    RESPIROLOGY, 2016, 21 (02) : 329 - 337
  • [50] Evolution of Habitat-Dependent Antibiotic Resistance in Pseudomonas aeruginosa
    Laborda, Pablo
    Martinez, Jose Luis
    Hernando-Amado, Sara
    MICROBIOLOGY SPECTRUM, 2022, 10 (04):